A detailed history of Woodline Partners LP transactions in Nkarta, Inc. stock. As of the latest transaction made, Woodline Partners LP holds 629,358 shares of NKTX stock, worth $1.7 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
629,358
Previous 628,129 0.2%
Holding current value
$1.7 Million
Previous $3.71 Million 23.38%
% of portfolio
0.03%
Previous 0.04%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$4.52 - $8.0 $5,555 - $9,832
1,229 Added 0.2%
629,358 $2.84 Million
Q2 2024

Aug 14, 2024

BUY
$5.27 - $10.82 $15,809 - $32,460
3,000 Added 0.48%
628,129 $3.71 Million
Q1 2024

May 15, 2024

BUY
$5.59 - $15.71 $3.49 Million - $9.82 Million
625,129 New
625,129 $6.76 Million

Others Institutions Holding NKTX

About Nkarta, Inc.


  • Ticker NKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,656,800
  • Market Cap $131M
  • Description
  • Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...
More about NKTX
Track This Portfolio

Track Woodline Partners LP Portfolio

Follow Woodline Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.